Trade Ideas LLC identified Edwards Lifesciences EW as a pre market leader candidate In addition to specific proprietary factors Trade Ideas identified Edwards Lifesciences as such a stock due to the following factors Edwards Lifesciences Corporation provides products and technologies to treat structural heart disease and critically ill patients worldwide EW has a PE ratio of 4 Currently there are 14 analysts that rate Edwards Lifesciences a buy no analysts rate it a sell and 3 rate it a hold The average volume for Edwards Lifesciences has been 2 0 million shares per day over the past 30 days Edwards Lifesciences has a market cap of 19 1 billion and is part of the health care sector and health services industry The stock has a beta of 0 55 and a short float of 2 8 with 3 00 days to cover Shares are up 11 7 year to date as of the close of trading on Thursday